KayoThera’s Post

Excited to share the latest article in the Journal of Experimental Medicine on the intricate role of Vitamin A and retinoid signaling in human health! This publication highlights the crucial work we're doing at KayoThera in inhibiting this pathway. While Vitamin A is essential for our well-being, too much of it—or the use of synthetic retinoids—can lead to serious health issues, including hyperlipidemia, heart failure, hypothyroidism, and even a delayed cancer-promoting effect. This paper dives deep into how diseases like #diabetes, #obesity, and #cancer exploit this nuclear receptor pathway and explores new therapeutic strategies to combat these conditions. Many thanks to Mark Esposito, Ph.D, Yibin Kang, and John Amory for their vital contributions to this article. Your expertise and collaboration were instrumental in bringing this research to life! https://lnkd.in/gkd9VpUm

We are thrilled to announce that Mark Esposito, Ph.D will be speaking at the International Retinoids Conference VII on Monday, July 8th, during Session 3. If you are attending the Federation of American Societies for Experimental Biology (FASEB) Science Research Conference in Saint Paul, be sure to join us for his talk on “ALDH1a Enzyme Expression Activates Retinoid Nuclear Receptor Signaling to Drive Disease Progression in Diabetes, Obesity, and Cancer.” #IRSRC #retinoid

We are thrilled to announce that KayoThera, Inc. has been selected for the NIH Company Showcase at #BIO2024 in San Diego. This prestigious opportunity will allow us to share the latest updates on our pipeline on a global stage. We are profoundly honored and grateful for the support of the National Institutes of Health. Join Mark Esposito, Ph.D, Vice President of R&D and co-founder, on Wednesday, June 5 at 11:45 AM in Company Presentation Theater 4, located in Hall A of the Exhibition Hall. See you in sunny San Diego! #nih #bio2024

We had the great fortune to be selected as the most memorable presenter at last week's BioNJ conference! It was great to be back in New Jersey and reconnect with the New Jersey Health Foundation, Inc. team!

We're thrilled to announce that KayoThera will be sharing the latest updates on our pipeline at BioNJ's 14th Annual Partnering Conference on May 14th. Join us as Mark Esposito, Ph.D our esteemed Vice President of R&D and co-founder, shares insights into our groundbreaking work. Don't miss out on this opportunity to discover more about our innovative approach to transforming healthcare. See you there! #BioNJ #Innovation #HealthcareRevolution

Join us as Kayothera provides updates on our pipeline at Life Science Innovation NorthWest! Our session is on April 18th at 11 am.